)
ABVC BioPharma (ABVC) investor relations material
ABVC BioPharma Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Special meeting scheduled for October 8, 2026, to be held virtually for shareholder participation and efficiency.
Three key proposals: approval of 2026 Equity Incentive Plan, ratification of equity awards since February 16, 2026, and authorization to issue shares for land acquisitions in Taiwan.
Board unanimously recommends voting in favor of all proposals.
Record date for voting eligibility is September 14, 2026; each share has one vote.
Voting matters and shareholder proposals
Proposal 1: Approve the 2026 Equity Incentive Plan, replacing the 2016 Plan, with a new formula for share pool and annual evergreen provision.
Proposal 2: Ratify equity awards (600,000 shares) granted to two advisors since February 16, 2026, pending approval of the new plan.
Proposal 3: Authorize issuance of up to 1,600,653 shares at no less than $1.00 per share for acquisition of land in Taoyuan and Hualien, Taiwan, to comply with Nasdaq rules.
All proposals require a majority of votes cast for approval.
Board of directors and corporate governance
Board members, including Ms. Shuling Jiang, are involved in related-party transactions and subject to audit committee review.
Board retains authority to determine final terms of land acquisition and share issuance.
- Approval sought for new equity plan, equity award ratification, and share issuance for Taiwan land deal.ABVC
Proxy filing - Shareholders will vote on a new equity plan, award ratification, and major share issuance for land acquisitions.ABVC
Proxy filing - Net loss narrowed, no revenue generated, and going concern risks persist amid restructuring.ABVC
Q2 2026 - Shareholders will vote on a new equity plan, equity award ratification, and share issuance for a Taiwan land deal.ABVC
Proxy filing - Q1 2026 saw a $1.69M net loss, no revenue, and a $4.74M working capital deficit.ABVC
Q1 2026 - Shareholders will vote on director re-elections, auditor ratification, and an equity plan increase.ABVC
Proxy Filing - Net loss increased to $8.4M in 2025 with no revenue recognized and ongoing going concern risks.ABVC
Q4 2025 - Shareholders will vote on director re-elections, auditor ratification, and an equity plan increase.ABVC
Proxy Filing - Plant-based drug developer seeks up to $100M via shelf registration amid global expansion.ABVC
Registration Filing
Next ABVC BioPharma earnings date
Next ABVC BioPharma earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)